Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
UK STAR logo

The UKSTAR (UK Study of tendo Achilles Rehabilitation) trial has opened its first pilot site for recruitment. King’s College Hospital in London is now recruiting patients for the trial which is comparing plaster casts to walking boots for patients who have suffered an Achilles tendon rupture and are being treated non-operatively. The trial will gradually be rolled out with the aim of eventually opening the trial in at least 22 hospitals across the UK.

Participants who are aged 16 or over, have suffered a primary Achilles tendon rupture and are being treated non-operatively will be eligible to take part. The primary outcome for the trial is to quantify and draw inferences on observed differences in Achilles Tendon Rupture Score (a patient reported outcome) between the trial treatment groups at 9 months after injury. The trial will also collect important information for secondary outcomes on quality of life, complications, resource use, costs and comparative cost effectiveness

Similar stories

WHiTE Four trial results!

OCTRU

The WHiTE Four trial has now published its results in The Bone & Joint journal.

FUTURE GB Trial opens to recruitment!

OCTRU

The FUTURE GB Trial has received OCTRU Green Light approval and is now open to recruitment!

ARCADIAN trial opens to recruitment!

OCTRU

The ARCADIAN trial has received OCTRU Green Light approval and has now begun to open sites to recruitment!

HOPE-e study resumes recruitment of women with painful osteoarthritis in the hand

Main OCTRU

Researchers in Oxford are looking to recruit women who have painful osteoarthritis in joints of their hands, after resuming a study that was paused due to the COVID crisis.

HUSH trial opens to recruitment!

OCTRU

The HUSH trial has received OCTRU Green Light approval and is now open to recruitment!

Oxford researchers start new trial on the use of anti-TNF to treat Covid-19 in care homes

Main OCTRU Trials

Researchers at the University of Oxford are starting a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with COVID-19 in the community, especially care homes. The AVID-CC trial, which will be conducted by Oxford Clinical Trials Research Unit (OCTRU), will enrol up to 750 patients from community care settings throughout the UK.